01 1Kyorin Pharmaceutical Group Facilities Co., Ltd. Noshiro Plant
01 1Handok Co., Ltd.
01 1Gatifloxacin 1.5 hydrate
01 1Japan
Registrant Name : Handok Co., Ltd.
Registration Date : 2013-05-07
Registration Number : 20130507-174-I-282-01
Manufacturer Name : Kyorin Pharmaceutical Group ...
Manufacturer Address : 1, Matsubara, Noshiro-shi, Akita, 016-0000, Japan
A gatifloxacin anhydrous manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of gatifloxacin anhydrous, including repackagers and relabelers. The FDA regulates gatifloxacin anhydrous manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. gatifloxacin anhydrous API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of gatifloxacin anhydrous manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A gatifloxacin anhydrous supplier is an individual or a company that provides gatifloxacin anhydrous active pharmaceutical ingredient (API) or gatifloxacin anhydrous finished formulations upon request. The gatifloxacin anhydrous suppliers may include gatifloxacin anhydrous API manufacturers, exporters, distributors and traders.
click here to find a list of gatifloxacin anhydrous suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a gatifloxacin anhydrous Drug Master File in Korea (gatifloxacin anhydrous KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of gatifloxacin anhydrous. The MFDS reviews the gatifloxacin anhydrous KDMF as part of the drug registration process and uses the information provided in the gatifloxacin anhydrous KDMF to evaluate the safety and efficacy of the drug.
After submitting a gatifloxacin anhydrous KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their gatifloxacin anhydrous API can apply through the Korea Drug Master File (KDMF).
click here to find a list of gatifloxacin anhydrous suppliers with KDMF on PharmaCompass.
We have 1 companies offering gatifloxacin anhydrous
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
